PROCEPT BioRobotics Corp PRCT
Nasdaq · stock · Surgical & Medical Instruments & Apparatus · website · IPO 2021-09-15
PROCEPT BioRobotics Corp statistics & valuation
Market cap$1.3B
P / S4.2×
P / B3.5×
Net margin-31.0%
Return on equity-26.1%
FCF margin-18.9%
Net cash$234.9M
Enterprise value USD$1.0B
Earnings yield EBIT/EV-9.9%
Return on capital-23.5%
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else from the latest financial reports.
Profitability & efficiency
Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Gross margin | 63.7% | 61.1% | 52.2% | 49.4% | 46.0% | -16.3% |
| Operating margin | -33.7% | -43.0% | -80.2% | -107.6% | -157.1% | -619.4% |
| Net margin | -31.0% | -40.7% | -77.8% | -116.2% | -173.6% | -687.0% |
| FCF margin | -18.9% | -46.2% | -97.8% | -110.7% | -168.0% | -629.5% |
| Return on assets | -18.8% | -17.1% | -26.2% | -28.2% | -17.8% | -42.1% |
| Return on equity | -26.1% | -22.7% | -37.7% | -44.2% | -22.4% | 29.0% |
| Debt / equity | 0.14× | 0.13× | 0.18× | 0.26× | 0.19× | -0.27× |
| Current ratio | 6.85 | 9.07 | 7.63 | 7.73 | 20.08 | 7.59 |
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.